skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: BMJ Journals - NESLi2 remover tipo de recurso: Anais de Congresso remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
OP0048 RISK OF FLARE AND DAMAGE ACCRUAL AFTER TAPERING GLUCOCORTICOIDS IN SEROLOGICALLY ACTIVE CLINICALLY QUIESCENT PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
OP0048 RISK OF FLARE AND DAMAGE ACCRUAL AFTER TAPERING GLUCOCORTICOIDS IN SEROLOGICALLY ACTIVE CLINICALLY QUIESCENT PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

OP0048 RISK OF FLARE AND DAMAGE ACCRUAL AFTER TAPERING GLUCOCORTICOIDS IN SEROLOGICALLY ACTIVE CLINICALLY QUIESCENT PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Katsumata, Y ; Inoue, E ; Harigai, M ; Kandane-Rathnayake, R ; Louthrenoo, W ; Hoi, A ; Golder, V ; Lau, C S ; Cho, J ; Lateef, A ; Chen, Y H ; Luo, S F ; Wu, Y J Jan ; Hamijoyo, L ; Z Li ; Sockalingam, S ; Navarra, S ; Zamora, L ; Hao, Y ; Zhang, Z ; Chan, M ; Oon, S ; K Ng ; Kikuchi, J ; Takeuchi, T ; Goldblatt, F ; S O’neill ; Tugnet, N ; Law, A ; Bae, S C ; Tanaka, Y ; Ohkubo, N ; Kumar, S ; Nikpour, M ; Morand, E F

Annals of the rheumatic diseases, 2023, Vol.82 (Suppl 1), p.31-32 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
2
POS1481 INFORMING TRIAL MEASUREMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS: FREQUENCY OF DOMAIN-SPECIFIC DISEASE ACTIVITY IN A MULTI-NATIONAL OBSERVATIONAL COHORT
POS1481 INFORMING TRIAL MEASUREMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS: FREQUENCY OF DOMAIN-SPECIFIC DISEASE ACTIVITY IN A MULTI-NATIONAL OBSERVATIONAL COHORT
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

POS1481 INFORMING TRIAL MEASUREMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS: FREQUENCY OF DOMAIN-SPECIFIC DISEASE ACTIVITY IN A MULTI-NATIONAL OBSERVATIONAL COHORT

Connelly, K ; Kandane-Rathnayake, R ; Golder, V ; Louthrenoo, W ; Chen, Y H ; Cho, J ; Lateef, A ; Hamijoyo, L ; Luo, S F ; Wu, Y J Jan ; Navarra, S ; Zamora, L ; Z LI ; Sockalingam, S ; Katsumata, Y ; Harigai, M ; Hao, Y ; Zhang, Z ; Chan, M ; Kikuchi, J ; Takeuchi, T ; Oon, S ; Bae, S C ; Goldblatt, F ; S O’neill ; K Ng ; Law, A ; Basnayake, B ; Tugnet, N ; Kumar, S ; Tee, C ; Tee, M ; Tanaka, Y ; Lau, C S ; Nikpour, M ; Hoi, A ; Morand, E F

Annals of the rheumatic diseases, 2023, Vol.82 (Suppl 1), p.1095-1096 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
3
BIIB059, A HUMANIZED MONOCLONAL ANTIBODY TARGETING BDCA2 ON PLASMACYTOID DENDRITIC CELLS (PDC), SHOWS DOSE-RELATED EFFICACY IN THE PHASE 2 LILAC STUDY IN PATIENTS (PTS) WITH ACTIVE CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
BIIB059, A HUMANIZED MONOCLONAL ANTIBODY TARGETING BDCA2 ON PLASMACYTOID DENDRITIC CELLS (PDC), SHOWS DOSE-RELATED EFFICACY IN THE PHASE 2 LILAC STUDY IN PATIENTS (PTS) WITH ACTIVE CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

BIIB059, A HUMANIZED MONOCLONAL ANTIBODY TARGETING BDCA2 ON PLASMACYTOID DENDRITIC CELLS (PDC), SHOWS DOSE-RELATED EFFICACY IN THE PHASE 2 LILAC STUDY IN PATIENTS (PTS) WITH ACTIVE CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)

Werth, V ; Furie, R ; Romero-Diaz, J ; Navarra, S ; Kalunian, K ; Van Vollenhoven, R ; Nyberg, F ; Kaffenberger, B ; Sheikh, S ; Radunovic, G ; Huang, X ; Carroll, H ; Gaudreault, F ; Meyers, A ; Barbey, C ; Musselli, C ; Franchimonton, N

ANNALS OF THE RHEUMATIC DISEASES, 2020, Vol.79, p.120 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
REMISSION IN SLE: CONSENSUS FINDINGS FROM A LARGE INTERNATIONAL PANEL ON DEFINITIONS OF REMISSION IN SLE (DORIS)
REMISSION IN SLE: CONSENSUS FINDINGS FROM A LARGE INTERNATIONAL PANEL ON DEFINITIONS OF REMISSION IN SLE (DORIS)
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

REMISSION IN SLE: CONSENSUS FINDINGS FROM A LARGE INTERNATIONAL PANEL ON DEFINITIONS OF REMISSION IN SLE (DORIS)

van Vollenhoven, RF ; Aranow, C ; Bertsias, G ; Bonfa, E ; Cervera, R ; Costedoat-Chalumeau, N ; Dorner, T ; Houssiau, F ; Lerstrom, K ; Morand, E ; Mosca, M ; Navarra, S ; Petri, M ; Urowitz, M ; Voskuijl, A ; Voss, A ; Ward, M ; Werth, V ; Schneider, M

ANNALS OF THE RHEUMATIC DISEASES, 2015, Vol.74, p.103 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
PREDICTORS FOR SLE FLARES: BASELINE DISEASE ACTIVITY AND DEMOGRAPHIC CHARACTERISTICS FROM THE BLISS TRIALS' COMBINED PLACEBO GROUPS
PREDICTORS FOR SLE FLARES: BASELINE DISEASE ACTIVITY AND DEMOGRAPHIC CHARACTERISTICS FROM THE BLISS TRIALS' COMBINED PLACEBO GROUPS
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

PREDICTORS FOR SLE FLARES: BASELINE DISEASE ACTIVITY AND DEMOGRAPHIC CHARACTERISTICS FROM THE BLISS TRIALS' COMBINED PLACEBO GROUPS

van Vollenhoven, RF ; Petri, M ; Levy, RA ; Navarra, S ; Buyon, J ; Zhong, ZJ ; Freimuth, W ; Cervera, R

ANNALS OF THE RHEUMATIC DISEASES, 2013, Vol.71, p.540 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
BASELINE LABORATORY CHARACTERISTICS FROM THE COMBINED PLACEBO GROUPS IN THE BLISS TRIALS ARE PREDICTIVE OF SEVERE FLARE AT 24 WEEKS
BASELINE LABORATORY CHARACTERISTICS FROM THE COMBINED PLACEBO GROUPS IN THE BLISS TRIALS ARE PREDICTIVE OF SEVERE FLARE AT 24 WEEKS
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

BASELINE LABORATORY CHARACTERISTICS FROM THE COMBINED PLACEBO GROUPS IN THE BLISS TRIALS ARE PREDICTIVE OF SEVERE FLARE AT 24 WEEKS

Petri, M ; van Vollenhoven, RF ; Levy, RA ; Navarra, S ; Cervera, R ; Zhong, ZJ ; Freimuth, W ; Buyon, J

ANNALS OF THE RHEUMATIC DISEASES, 2013, Vol.71, p.538 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.